-
The second phase of the Merck China Biosafety Testing and Experimental Center project has been completed and officially put into use
On November 21st, Merck announced that the second phase of its China Biosafety Testing and Experimental Center project was completed and officially opened in Shanghai, adding an additional 1500 squar ... -
Genxi Biotech's US stock market surged by over 70% before trading
On December 26th, the US stock market of Genxi Biotechnology surged by over 70% before the market, and AstraZeneca acquired Genxi Biotechnology for $1.2 billion. -
Genxi Biotechnology merged with AstraZeneca Group and will be delisted from NASDAQ
Nanfang Finance and Economics, on February 23, according to the official account of Genxi Biotechnology WeChat, Genxi Biotechnology Group announced that it had officially completed the merger agreeme ...